Psyence Biomedical Ltd [NASDAQ: PBM] gained 42.47% on the last trading session, reaching $5.3 price per share at the time.
Psyence Biomedical Ltd represents 0.08 million in outstanding shares, while the company has a total market value of $3.78 million with the latest information. PBM stock price has been found in the range of $4.36 to $5.52.
If compared to the average trading volume of 1.65M shares, PBM reached a trading volume of 25770570 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for PBM stock
Psyence Biomedical Ltd [PBM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 63.58. With this latest performance, PBM shares gained by 69.87% in over the last four-week period, additionally sinking by -4.86% over the last 6 months – not to mention a drop of -68.48% in the past year of trading.
Psyence Biomedical Ltd (PBM) Capital Structure & Debt Analysis
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
An analysis of Institutional ownership at Psyence Biomedical Ltd [PBM]
There are presently around $44.69%, or 44.90%% of PBM stock, in the hands of institutional investors. The top three institutional holders of PBM stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.46 million shares, which is approximately 23.9034%. CANTOR FITZGERALD, L. P., holding 0.34 million shares of the stock with an approximate value of $$0.1 million in PBM stocks shares; and CANTOR FITZGERALD, L. P., currently with $$6866.0 in PBM stock with ownership which is approximately 1.1814%.
